Chestnut Hill, MA, United States of America

Shaozhen Xie

This inventor holds 1 USPTO granted patent. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shaozhen Xie. Retrieved from https://idiyas.com/inventor/shaozhen-xie

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Shaozhen Xie in Cancer Treatment

Introduction

Shaozhen Xie is a notable inventor based in Chestnut Hill, MA (US). He has made significant contributions to the field of cancer treatment, particularly in addressing brain metastases. His innovative approaches have the potential to improve therapeutic outcomes for patients suffering from this challenging condition.

Latest Patents

Shaozhen Xie holds a patent titled "Methods for treating brain metastases using combinations of anti-PI3K and anti-mTOR agents." This invention focuses on the use of synergistic combinations of anti-PI3K and anti-mTOR therapies. The findings suggest that blocking both PI3K and mTOR can provide a therapeutic benefit for treating brain metastases. He has 1 patent to his name, showcasing his commitment to advancing medical science.

Career Highlights

Xie is affiliated with the Dana-Farber Cancer Institute Inc., where he continues to work on innovative cancer therapies. His research is pivotal in developing new treatment strategies that can enhance patient care and outcomes.

Collaborations

Throughout his career, Shaozhen Xie has collaborated with esteemed colleagues, including Jing Ni and Jean Zhao. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in cancer research.

Conclusion

Shaozhen Xie's contributions to cancer treatment through his innovative patent demonstrate his dedication to improving patient outcomes. His work at the Dana-Farber Cancer Institute Inc. and collaborations with fellow researchers highlight the importance of teamwork in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…